Literature DB >> 32725249

Anxiety and Depression in Primary Hyperhidrosis: An Observational Study of 95 Consecutive Swedish Outpatients.

Johannes Kjeldstrup Kristensen1, Sören Möller, Dorthe Grejsen Vestergaard, Hans-Henrik Horsten, Carl Swartling, Anette Bygum.   

Abstract

is missing (Short communication).

Entities:  

Keywords:  anxiety; body image; depression; primary hyperhidrosis

Mesh：

Year:  2020        PMID： 32725249      PMCID： PMC9207642          DOI： 10.2340/00015555-3598

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


  8 in total

1.  Beyond body image as a trait: the development and validation of the Body Image States Scale.

Authors:  Thomas F Cash; Emily C Fleming; Jenny Alindogan; Laura Steadman; Abigail Whitehead
Journal:  Eat Disord       Date:  2002       Impact factor: 3.222

Review 2.  International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results.

Authors:  C Herrmann
Journal:  J Psychosom Res       Date:  1997-01       Impact factor: 3.006

3.  Hospital Anxiety and Depression Scale (HAD): some psychometric data for a Swedish sample.

Authors:  J Lisspers; A Nygren; E Söderman
Journal:  Acta Psychiatr Scand       Date:  1997-10       Impact factor: 6.392

Review 4.  The validity of the Hospital Anxiety and Depression Scale. An updated literature review.

Authors:  Ingvar Bjelland; Alv A Dahl; Tone Tangen Haug; Dag Neckelmann
Journal:  J Psychosom Res       Date:  2002-02       Impact factor: 3.006

5.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

6.  Association of Primary Hyperhidrosis with Depression and Anxiety: A Systematic Review.

Authors:  Johannes Kjeldstrup Kristensen; Dorthe Grejsen Vestergaard; Carl Swartling; Anette Bygum
Journal:  Acta Derm Venereol       Date:  2020-01-30       Impact factor: 3.875

7.  The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries.

Authors:  Florence J Dalgard; Uwe Gieler; Lucia Tomas-Aragones; Lars Lien; Francoise Poot; Gregor B E Jemec; Laurent Misery; Csanad Szabo; Dennis Linder; Francesca Sampogna; Andrea W M Evers; Jon Anders Halvorsen; Flora Balieva; Jacek Szepietowski; Dmitry Romanov; Servando E Marron; Ilknur K Altunay; Andrew Y Finlay; Sam S Salek; Jörg Kupfer
Journal:  J Invest Dermatol       Date:  2014-12-18       Impact factor: 8.551

8.  Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis.

Authors:  Gleide Maria Gatto Bragança; Sonia Oliveira Lima; Aloisio Ferreira Pinto Neto; Lucas Menezes Marques; Enaldo Vieira de Melo; Francisco Prado Reis
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896
  8 in total
  5 in total

Review 1.  Treatment of Depression with Botulinum Toxin.

Authors:  Marc Axel Wollmer; Michelle Magid; Tillmann H C Kruger; Eric Finzi
Journal:  Toxins (Basel)       Date:  2022-05-31       Impact factor: 5.075

2.  The Impact of COVID-19 on Hyperhidrosis Patients in the Mental Health and Quality of Life: A Web-Based Surveillance Study.

Authors:  Wongi Woo; Jooyoung Oh; Bong Jun Kim; Jongeun Won; Duk Hwan Moon; Sungsoo Lee
Journal:  J Clin Med       Date:  2022-06-21       Impact factor: 4.964

3.  Hyperhidrosis Comorbidities and Treatments: A Register-based Study among 511 Subjects.

Authors:  Sanna-Liisa Heiskanen; Jani Niskala; Jari Jokelainen; Kaisa Tasanen; Laura Huilaja; Suvi-Päivikki Sinikumpu
Journal:  Acta Derm Venereol       Date:  2022-02-28       Impact factor: 3.875

4.  Decreased work productivity due to primary palmar hyperhidrosis. What is the cost?

Authors:  J K Kristensen; C Nielsen
Journal:  Skin Health Dis       Date:  2021-04-05

5.  Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety.

Authors:  M Axel Wollmer; Tigran Makunts; Tillmann H C Krüger; Ruben Abagyan
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.